TG-6050
- Generic Name
- TG-6050
A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir)
- First Posted Date
- 2023-03-29
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Transgene
- Target Recruit Count
- 36
- Registration Number
- NCT05788926
- Locations
- 🇫🇷
Hôpital Européen Georges Pompidou, Paris, France
🇫🇷Institut Bergonié, Bordeaux, France
🇫🇷Hôpital Timone, Marseille, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath